Chemed shareholders elect all director nominees, approve 2025 stock plan and advisory compensation at annual meeting

CHEMED CORP

All nine director nominees elected; Kevin McNamara received 12,805,746 for vs 203,421 against.
Shareholders approved 2025 Stock Incentive Plan with 11,536,322 for, 1,473,289 against.
Ratified PwC as independent auditor for FY2024 with 13,250,853 for, 365,426 against.
Non-binding advisory vote on executive compensation approved: 11,039,768 for, 1,656,237 against.
Shareholder proposal to reduce special meeting threshold to 10% not presented due to proponent absence.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.